sought to determine an optimal radiation dose that maximized production of IFN-1 while minimizing TREX1 expression using a mammary carcinoma mouse model treated with RT and an antibody against anti-cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). This evidence concerns the gene CTLA4 and breast carcinoma.